News
ORALOGICA Welcomes Dr. Steven Fox to our Advisory Board
Posted by ORALOGICA on March 12, 2018
SCOTTSDALE, AZ – March 12, 2018 –ORALOGICA, LLC. the emerging leader in retail oral care products, today announced the engagement of Dr. Steven R. Fox as a strategic advisor to the management team.
Widely viewed as an icon in the dental profession and credited for revolutionizing oral care on a global basis, Dr. Fox has collaborated with the U.S. government and the American Dental Association to develop and commercialize many of the products used in oral care today. He has served on the faculties of the Harvard School of Dental Medicine and NYU School of Dentistry, and as an officer of Harvard University.
As Founder, CEO and Chairman of Enamelon, Inc., he helped to pioneer the first technology to re-mineralize tooth structure, spearheaded its creation as an over-the-counter product and took the company public on a national stock exchange, raising $80 million over an 8-year period. Dr. Fox is the recipient of the Medal of Freedom from the United States Senate and the Ernst and Young Entrepreneur of the Year Award. He also serves as Chairman of the Board of The Rebel Group, Inc., a global strategy, and financial advisory firm.
“ORALOGICA has created a line of safe, highly effective and innovative products unlike any other. Oralogica will revolutionize retail oral care products. I look forward to contributing my industry, financial and business-building expertise to help ORALOGICA accelerate the Company’s many exciting growth initiatives.” Says Dr. Fox.
Mindi Osborn, CEO of ORALOGICA, added, “Dr. Fox has a meaningful role in helping ORALOGICA to establish market leadership. We are delighted to have Dr. Fox aboard and we know that with his keen business mind and tremendous industry expertise we will achieve our rapid market penetration as planned.”
About ORALOGICA
ORALOGICA is a personal-care product company created from a passion to provide consumers with superior products that are healthy and effective.
For more information, please visit www.oralogica.com
COMPANY CONTACT:
Kevin Flatau
612.518.3030
Info@ORALOGICA.com
Posted by iRemedy on November 15, 2017
STUART, FL – November 15, 2017 – iRemedy Healthcare Companies, Inc. (“iRemedy” or “the Company”), parent of iRemedySupply.com and the industry transformative iRemedy ecommerce platform, today announced the engagement of Dr. Steven R. Fox as a strategic corporate advisor to management.
Widely viewed as an icon in the dental profession and credited for revolutionizing oral care on a global basis, Dr. Fox has collaborated with the U.S. government and the American Dental Association to develop and commercialize many of the products used in oral care today. He is the only doctor in New York City teaching cosmetic dentistry who has served on the faculties of the Harvard School of Dental Medicine and NYU School of Dentistry, and as an officer of Harvard University. The author of the book Dentistry in the 21st Century and an accomplished business entrepreneur, Dr. Fox has frequently appeared on national and international television programming such as CNBC, Fox News and CNN; and has been featured in hundreds of newspapers and magazines, including The Wall Street Journal and Forbes Magazine.
As Founder, CEO and Chairman of Enamelon, Inc., he helped to pioneer the first technology to re-mineralize tooth structure, spearheaded its creation as an over-the-counter product and took the company public company on a national stock exchange, raising $80 million over an 8-year period. Recognized for his groundbreaking work in advancing oral care, Dr. Fox is the recipient of the United States Medal of Freedom and the Ernst and Young Entrepreneur of the Year Award. In addition to owning and operating New York City’s premier cosmetic dentistry practice, he also serves as Chairman of the Board of The Rebel Group, Inc., a global strategy and financial advisory firm that provides specialized consulting services to healthcare entrepreneurs and emerging healthcare companies. Dr. Fox received his Bachelor of Arts degree from the University of Rochester and his Doctor of Dental Surgery degree from New York University.
Commenting on his engagement, Dr. Fox stated, “I believe the iRemedy ecommerce platform holds profound potential to up-end the U.S. healthcare supply chain and revolutionize how medical products are delivered to and through physicians, dentists and healthcare institutions. As such, I look forward to contributing my industry, financial and business-building expertise and experience to help iRemedy’s leadership refine and accelerate the Company’s many exciting growth initiatives.”
Tony Paquin, Co-Founder and CEO of iRemedy, added, “If iRemedy is to succeed in achieving our objectives, we recognize the need to tap and leverage proven industry experts to help guide our tactical decision-making processes and market penetration strategies. Given the depth and breadth of Dr. Fox’s multi-faceted experience – particularly with emerging healthcare technology ventures – we believe he will play a meaningful role in helping iRemedy to establish noted market leadership. We are thrilled to have him with us.”
About The iRemedy Healthcare Companies
iRemedy owns and operates iRemedySupply.com, fast emerging as America’s preferred healthcare ecommerce marketplace where healthcare consumers come to buy medical supplies, drugs, devices and technologies. Since its market launch in December 2015, thousands of consumers, physicians, nurses, dentists and enterprise users of iRemedy’s Software as a Service (“SaaS”) healthcare ecommerce solutions have joined the fast growing iRemedy community. Built from the ground-up by proven healthcare technology experts, the iRemedy platform brings modern ecommerce-driven, cost-reducing solutions to healthcare by delivering the quality, security and end-to-end supply chain management required by the industry, elegantly combining on-line requisitioning, ordering and purchasing with robust back-end inventory management and fulfillment services. iRemedy further enhances its electronic marketplace value proposition with fully integrated, SaaS-enabled tools available to iRemedy’s professional users, including managed supply chain solutions, turnkey remote patient monitoring, drug sample program and product recommendation capabilities. For more information, please visit www.iremedy.com.
COMPANY CONTACTS:
Keisha Graham
Director of Marketing
407-395-4283 | keisha@iremedy.com